Cosmos Health Inc. (COSM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cosmos Health Inc. (COSM) has a cash flow conversion efficiency ratio of -0.249x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.60 Million) by net assets ($18.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See COSM net asset quality index to measure how much of total assets are equity-financed.
Cosmos Health Inc. - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Cosmos Health Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check COSM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Cosmos Health Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cosmos Health Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SKK Holdings Limited
NASDAQ:SKK
|
N/A |
|
The Motor & General Finance Limited
NSE:MOTOGENFIN
|
-0.003x |
|
Wong Engineering Corporation Bhd
KLSE:7050
|
-0.012x |
|
Aurora Spine Corp
V:ASG
|
-0.004x |
|
Vistry Group PLC
LSE:VTY
|
0.059x |
|
Ostasiatiske Kompagni A/S
CO:OKEAC
|
0.526x |
|
Ecoscience International Berhad
KLSE:0255
|
0.088x |
|
Greentech Metals Ltd
AU:GRE
|
-0.056x |
Annual Cash Flow Conversion Efficiency for Cosmos Health Inc. (2010–2025)
The table below shows the annual cash flow conversion efficiency of Cosmos Health Inc. from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Cosmos Health Inc. worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $18.42 Million | $-8.45 Million | -0.458x | -45.76% |
| 2024-12-31 | $24.53 Million | $-7.72 Million | -0.315x | +27.49% |
| 2023-12-31 | $36.04 Million | $-15.64 Million | -0.434x | -15.69% |
| 2022-12-31 | $39.66 Million | $-14.87 Million | -0.375x | +76.86% |
| 2021-12-31 | $4.38 Million | $-7.10 Million | -1.621x | -158.63% |
| 2020-12-31 | $-4.16 Million | $-11.50 Million | 2.764x | +272.92% |
| 2019-12-31 | $-6.46 Million | $-4.79 Million | 0.741x | +58.10% |
| 2018-12-31 | $-3.32 Million | $-1.56 Million | 0.469x | -83.80% |
| 2017-12-31 | $-3.03 Million | $-8.76 Million | 2.893x | +138.52% |
| 2016-12-31 | $-1.75 Million | $-2.13 Million | 1.213x | +204.48% |
| 2015-12-31 | $-1.25 Million | $-497.09K | 0.398x | -66.58% |
| 2014-12-31 | $5.47 Million | $6.53 Million | 1.192x | +107.70% |
| 2013-12-31 | $-53.68K | $831.40K | -15.487x | -67992.51% |
| 2012-12-31 | $-1.36K | $31.00 | -0.023x | -100.12% |
| 2011-12-31 | $-4.76K | $-87.29K | 18.330x | +360.38% |
| 2010-12-31 | $-17.48K | $-69.60K | 3.982x | -- |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more